Solid Organ Transplant Pharmacy

Graduates from this program will be proficient in the care of transplant recipients within all aspects of the transplant process, including pre-transplant, during the acute care phase of transplant, and ongoing post-transplant care. Michigan Medicine is a university teaching hospital providing an exceptional environment to engage our residents in direct patient care activities, research experiences, and teaching opportunities.  

Program Purpose 

PGY2 residency programs build upon Doctor of Pharmacy (PharmD) education and PGY1 pharmacy residency training to develop pharmacist practitioners with knowledge, skills, and abilities as defined in the educational competency areas, goals, and objectives for advanced practice areas. Residents who successfully complete PGY2 residency programs are prepared for advanced patient care or other specialized positions, and board certification in the advanced practice area, if available.

The PGY2 Solid Organ Transplant Pharmacy Residency program builds on Doctorate of Pharmacy education and PGY1 pharmacy residency training to contribute to the development of clinical pharmacists in advanced or specialized practice in solid organ transplant pharmacotherapy. This PGY2 residency program provides residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care that improves medication therapy. Residents who successfully complete this accredited PGY2 residency should possess competencies that qualifies them for clinical pharmacist and/or faculty positions and position them to be eligible for attainment of board certification (i.e., BCTXP).